Skip to Content

Carl Zeiss Meditec AG CZMWF Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 85.00
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Investment Style Mid Growth
  • Day Range 85.00  –  86.86
  • Year Range 85.00  –  151.91
  • Market Cap 7.6024 Bil
  • Volume / Avg 148.0 /  54.1
  • Price / Sales 3.50
  • Price / Book 3.55
  • Forward Div Yield 1.02%
  • Trailing Div Yield 1.29%

Morningstar‘s Stock Analysis CZMWF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CZMWF

Company Profile CZMWF

Business Description

Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Goschwitzer Strasse 51-52
Jena, TH, 07745, DEU
Industry Medical Instruments & Supplies
Employees 4,224

Competitors & Peers CZMWF

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of CZMWF’s competitive advantage.

Carl Zeiss Meditec AG


Johnson & Johnson


Bausch Health Companies Inc

−$3.81 (4.29%) −$1.91 (1.20%) −$0.03 (0.27%)
Market Cap
7.60 Bil378.32 Bil4.03 Bil
Medical Instruments & Supplies Drug Manufacturers - General Drug Manufacturers - Specialty & Generic

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Carl Zeiss Meditec AG Stock

Yes. CZMWF has a forward dividend yield of 1.50%. See CZMWF’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CZMWF’s market cap is 7.60 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CZMWF’s stock style is Mid Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

CZMWF’s price/sales is 3.50.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

CZMWF’s price/forward earnings is 23.61.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

CZMWF’s price/book is 3.55.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See CZMWF’s valuation ratios compared to the Market Index.

CZMWF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CZMWF’s historical performance against its industry peers and the overall market.